Neumora Therapeutics Announces Initiation of Phase 1 Clinical Study Neumora Therapeutics, Inc. has initiated a Phase 1 clinical study of NMRA-898, a M4 positive allosteric modulator.
Vesper Solar 600 MW Texas Project The Vesper Solar 600 MW Texas project demonstrates how an agrivoltaics mindset can unlock prime sites fo…
Councils' Role in New Towns Success Peers have emphasized the importance of councils in making the New Towns programme a success. A…
Installing Microsoft Store in Windows Sandbox with PowerShell Script Windows Sandbox, a lightweight virtual desktop, can now have Microsof…
Isuzu FA Trophy Second Round Proper Draw Confirmed The draw for the Isuzu FA Trophy Second Round Proper has been confirmed, with 40 ties s…
Kymera Therapeutics Presents New Preclinical Data for KT-579 Kymera Therapeutics, Inc. announced the presentation of new preclinical data …
Rolex 24 Grid Expansion Not Possible Due to Pit Lane Space IMSA President John Doonan stated that expanding the Rolex 24 grid is currently…
Lululemon to Sell NFL Apparel in Fanatics Deal Lululemon has entered an arrangement with the NFL and Fanatics to develop a line of fan app…
Prairie Portraits: Alex Rapp The Prairie Portraits series features founders, funders and community builders from Nebraska's innovation and…
Abbott Directed to Provide Prescribing Details for Triamcinolone Hexacetonide Pre-Filled Syringe The Subject Expert Committee (SEC) under …
Senator Questions 946 Infra Projects SENATE Finance Committee Chair Senator Sherwin T. Gatchalian said about 946 projects worth P14.4 bill…